Back

Improved outcome by guideline-directed medical therapy in real-world heart failure patients despite low blood pressure and renal dysfunction

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Heart failure outcome Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Xiaojing Chen

West China Hospital, Sichuan University, Chengdu (China)

9 More presentations in this session

Presentation thumbnail
Machine-learning defined predictors of mortality in ischemic and non-ischemic heart failure patients undergoing CRT-P or CRT-D implantation
Associate Professor A. Kosztin (Budapest, HU)
Abstract
Presentation thumbnail
A possible independent contribution of liver stiffness to the development of heart failure in its early stage
Mr Y. Iwasaki (Tokyo, JP)
Abstract
Presentation thumbnail
Age, creatinine, and ejection fraction (ACEF) score continues to predictive prognosis in patients with ischemic cardiomyopathy
Doctor W. Chen (Guangzhou, CN)
Abstract
Presentation thumbnail
Comparison of inflammation based prognostic scores in patients with stable heart failure with reduced ejection fraction
Doctor H. Arfsten (Vienna, AT)
Abstract
Presentation thumbnail
A risk score for prediction of TIA/ischemic stroke in patients with heart failure and sinus rhythm
Associate Professor C. Hjalmarsson (Gothenburg, SE)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Heart failure outcome

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources